title: Resorcylidene aminoguanidine improves the pathologically reduced fluidity of erythrocyte membranes in diabetes mellitus.
authors.affiliation: Department of Biophysics, Comenius University, Bratislava, Slovakia. sikurova@fmph.uniba.sk
authors.forename: L
authors.initials: L
authors.lastname: Sikurová
authors.forename: J
authors.initials: J
authors.lastname: Dérerová
authors.forename: P
authors.initials: P
authors.lastname: Kvasnicka
authors.forename: I
authors.initials: I
authors.lastname: Waczulíková
authors.forename: J
authors.initials: J
authors.lastname: Cársky
authors.forename: O
authors.initials: O
authors.lastname: Ulicná
mesh_terms: D016880:Anisotropy; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D004910:Erythrocyte Membrane / Q000187:drug effects* / Q000502:physiology; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008560:Membrane Fluidity / Q000187:drug effects*
chemical_list: D006146:Guanidines; C115168:resorcylidene aminoguanidine